Erythromycin derivatives for Gram-positive infections disclosed by Hoechst Marion Roussel Oct. 13, 1998
New broad-spectrum anti-MRSA pyrrolidinone cephalosporin and water-soluble prodrug from Roche Oct. 6, 1998